Naito Tateaki

ナイトウタテアキ | 内藤立暁

所属機関・部署：
職名：医長
競争的資金等の研究課題 (1件)：

2021 - 2027 がん薬物療法を受ける患者の包括的がん悪液質アセスメントツールの開発と実装

論文 (307件)：

Rika Sato, Tateaki Naito, Haruyasu Murakami, Shota Omori, Haruki Kobayashi, Akira Ono, Nobuaki Mamesaya, Kazushige Wakuda, Ryo Ko, Hirotsugu Kenmotsu, et al. Correlation between cancer cachexia and psychosocial impact in older patients with advanced lung cancer undergoing chemotherapy. Asia-Pacific Journal of Oncology Nursing. 2025. 12. 100658-100658
Kenju Ando, Tateaki Naito, Satoshi Hamauchi, Keita Miura, Yuichiro Nishibori, Ayumi Tonsho, Suguru Matsuda, Meiko Morita, Motoki Sekikawa, Kosei Doshita, et al. The efficacy and safety of anamorelin among patients with diabetes. International journal of clinical oncology. 2024. 29. 8. 1115-1121
Yuko Iida, Kazushige Wakuda, Hirotsugu Kenmotsu, Kosei Doshita, Hiroaki Kodama, Naoya Nishioka, Eriko Miyawaki, Taichi Miyawaki, Nobuaki Mamesaya, Haruki Kobayashi, et al. Efficacy of second-line chemotherapy in patients with pulmonary large cell neuroendocrine carcinoma. Scientific reports. 2024. 14. 1. 7641-7641
Yuko Iida, Kazushige Wakuda, Takuya Kawata, Meiko Morita, Motoki Sekikawa, Kosei Doshita, Michitoshi Yabe, Hiroaki Kodama, Keita Miura, Noboru Morikawa, et al. Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer. Thoracic cancer. 2024. 15. 6. 477-485
頓所安祐美, 村上晴泰, 矢部道俊, 三浦啓太, 児玉裕章, 飯田由子, 豆鞘伸昭, 小林玄機, 高遼, 和久田一茂, et al. 臨床病期III期相当のNSCLC術後再発に対する化学放射線療法の検討. 肺癌. 2023. 63. 7. 1019-1019

MISC (469件)：

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る